WallStreetZenWallStreetZen

NASDAQ: FUSN
Fusion Pharmaceuticals Inc Earnings & Revenue

Buy FUSN

FUSN earnings and revenue history

Current Revenue
$2.0M
Current Earnings
-$83.4M
Current Profit Margin
-4,119.9%

FUSN Return on Equity

Current Company
-34.9%
Current Industry
6.9%
Current Market
38.4%
FUSN's Return on Equity (-34.9%)... subscribe to Premium to read more.
High Return on Equity Performance

FUSN Return on Assets

Current Company
-32.1%
Current Industry
5.1%
FUSN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

FUSN Return on Capital Employed

Current Company
-37.31%
Current Industry
-16.5%

FUSN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
FUSN$2.03M-$81.66M-$83.43MN/AN/A
VRCA$431.00k-$37.70M-$42.61M-96.41%N/A
CRIS$10.62M-$55.62M-$56.72M+5.03%N/A
AKUS$0.00-$93.54M-$97.57MN/AN/A
CYT$0.00-$48.75M-$49.74MN/AN/A

Fusion Pharmaceuticals Earnings & Revenue FAQ

What were FUSN's earnings last quarter?

On Invalid Date, Fusion Pharmaceuticals (NASDAQ: FUSN) reported Q1 2022 earnings per share (EPS) of -$0.46, up 9.52% year over year. Total Fusion Pharmaceuticals earnings for the quarter were -$19.91 million. In the same quarter last year, Fusion Pharmaceuticals's earnings per share (EPS) was -$0.42.

If you're new to stock investing, here's how to buy Fusion Pharmaceuticals stock.

What was FUSN's earnings growth in the past year?

As of Q3 2022, Fusion Pharmaceuticals's earnings has grown year over year. Fusion Pharmaceuticals's earnings in the past year totalled -$83.43 million.

What was FUSN's revenue last quarter?

On Invalid Date, Fusion Pharmaceuticals (NASDAQ: FUSN) reported Q1 2022 revenue of $585.00 thousand up Infinity% year over year. In the same quarter last year, Fusion Pharmaceuticals's revenue was $0.00.

What was FUSN's revenue growth in the past year?

As of Q3 2022, Fusion Pharmaceuticals's revenue has grown null year over year. Fusion Pharmaceuticals's revenue in the past year totalled $2.03 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.